Eli Lilly’s diabetes drug tirzepatide gets approval in China
ELI Lilly said on Tuesday (May 21) its diabetes drug tirzepatide has received approval from Chinese regulators, setting up intensifying ...
ELI Lilly said on Tuesday (May 21) its diabetes drug tirzepatide has received approval from Chinese regulators, setting up intensifying ...
ONE in eight US adults has tried medications from the fast-growing class of new diabetes and obesity drugs that includes ...
Smartwatches and rings that claim to measure blood sugar levels for medical purposes without piercing the skin could be dangerous ...
In recent months, there has been a swelling interest in using diabetes drugs to treat weight loss.Drugs with brand names ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2025 Forbes 40under40. All Rights Reserved.